Canada Digestive System Disorder Industry Outlook 2022 - 2026

See how Canada Digestive System Disorder performed compared to key markets such as Germany, Japan and South Korea.

Key Market Indicators

Sales of digestive system disorder medication in Canada are set to reach $4.2 billion by 2026. In 2021, the market was worth $3.9 billion, and has grown an average of 1.2% every year since 2017. Canada was the fourth largest market for digestive system disorder medication in 2021, with South Korea overtaking to reach $3.9 billion. Japan, South Korea, and Canada were the number 2, 3, and 4 spots, respectively.

Canada Digestive System Disorder Market Data and Forecasts

Canada Digestive System Disorder : how will it grow in the coming years?

Forecast: Digestive System Diseases Mortality in Canada
  • Units (Male Deaths) Per Hundred Thousand Men, Standardised Rates
  • 2024 to 2028
  • ReportLinker Research
Forecast: Peptic Ulcer Mortality in Canada
  • Units (Deaths) Per Hundred Thousand Persons
  • 2024 to 2028
  • ReportLinker Research
Forecast: Alimentary Tract and Metabolism Medicine Sales in Canada
  • Million Canadian Dollars
  • 2024 to 2028
  • ReportLinker Research
Forecast: Chronic Liver Diseases and Cirrhosis Mortality in Canada
  • Units (Female Deaths) Per Hundred Thousand Women, Standardised Rates
  • 2024 to 2028
  • ReportLinker Research
Forecast: Peptic Ulcer and Gastro-Oesophageal Reflux Diseases (GORD) Medicine Use in Canada
  • Units (Defined Daily Dosage) Per Thousand Persons Per Day
  • 2024 to 2028
  • ReportLinker Research
Forecast: Alimentary Tract and Metabolism Medicine Sales in Canada
  • Percent of Total Sales
  • 2024 to 2028
  • ReportLinker Research
Forecast: Alimentary Tract and Metabolism Medicine Sales in Canada
  • Million US Dollars
  • 2024 to 2028
  • ReportLinker Research
View More

Other Top Countries about Digestive System Disorder